Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$20.30 +0.23 (+1.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amneal Pharmaceuticals (AMRX) Capital Expenditures (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) posted Capital Expenditures of $30.7 million for Q2 2026, up 34.5% from $22.83 million a year earlier and up 275.5% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Capital Expenditures (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Amneal Pharmaceuticals was $72.94 million, up 7.1% year-over-year; for FY2025, it was $70.06 million, up 34.9% from FY2024.

  • Annual Capital Expenditures shows a five-year compound annual growth rate of 4.4% (FY2020 to FY2025).
  • In prior years, Amneal Pharmaceuticals' Capital Expenditures was $51.92 million in FY2024 (+20.1%), $43.22 million in FY2023 (-6.9%), $46.41 million in FY2022 (-2.8%) and $47.73 million in FY2021 (-15.4%).
  • The Q2 2026 figure stands as the highest quarterly Capital Expenditures in data going back to Q3 2017.
  • On a year-over-year basis, Capital Expenditures increased in six of the last eight quarters, with growth averaging 33.7%.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2023, with growth of 137.7%; the weakest was Q4 2021, with a decline of 40.8%.
  • According to Business Quant data, Capital Expenditures for the three prior quarters was $8.18 million (Q1 2026), $21.77 million (Q4 2025) and $12.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Amneal Pharmaceuticals 6.43 Bn 5.71 Bn 334.51 Mn 30.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.70 Mn
Mar 31, 2026 8.18 Mn
Dec 31, 2025 21.77 Mn
Sep 30, 2025 12.30 Mn
Jun 30, 2025 22.83 Mn
Mar 31, 2025 13.16 Mn
Dec 31, 2024 15.16 Mn
Sep 30, 2024 16.95 Mn
Jun 30, 2024 10.63 Mn
Mar 31, 2024 9.20 Mn
Dec 31, 2023 9.87 Mn
Sep 30, 2023 11.66 Mn
Jun 30, 2023 12.00 Mn
Mar 31, 2023 9.69 Mn
Dec 31, 2022 11.47 Mn
Sep 30, 2022 19.10 Mn
Jun 30, 2022 5.05 Mn
Mar 31, 2022 10.79 Mn
Dec 31, 2021 17.50 Mn
Sep 30, 2021 10.65 Mn
API Access

Amneal Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AMRX&period=max&api_key=YOUR_API_KEY